Alert Icon

Beware of scams

We are aware of scams coming from email and social media where people try to impersonate us. We will never ask you for money or your bank details.

Learn more about what to look out for and how to protect yourself

Life Sciences Investment Programme

The Life Sciences Investment Programme (LSIP) is a £200m initiative managed by British Patient Capital designed to address the growth equity finance gap faced by high-potential UK life sciences companies. This is expected to attract at least a further £400m of private investment.

Through LSIP, we make cornerstone commitments to later stage life sciences venture growth funds with a strong UK focus, typically investing between £50m and £100m in each successful fund.

Key features

  • Dedicated life sciences focus
  • Funds providing later-stage capital
  • UK presence in investment team
  • Minimum target fund size of £250m
  • Focus on funding UK companies

Find out more

For further information please see our Request for Proposals.

Download Request for Proposal (PDF 582.6 KB)

If you have any queries please contact [email protected]